1. Molecular classes of breast cancer and their clinical relevance

   • Per Eystein Lønning

   OriginalPaper 29 November 2009 Pages: 183 - 189

2. The role of pharmacogenetics in selection of breast cancer treatment

   • Roisin Connolly
   • Vered Stearns

   OriginalPaper 29 November 2009 Pages: 190 - 197

3. Minimal residual cancer and its clinical relevance

   • Brigitte Rack
   • Volkmar Müller
   • Wolfgang Janni

   OriginalPaper 29 November 2009 Pages: 198 - 206

4. Advances in endocrine therapy and its implications for translational research

   • Amna Sheri
   • Nicholas C. Turner
   • Ian E. Smith

   OriginalPaper 29 November 2009 Pages: 207 - 215

5. Advances in clinical trial designs for predictive biomarker discovery and validation

   • Richard Simon

   OriginalPaper 29 November 2009 Pages: 216 - 221

6. Therapeutic strategies to eliminate breast cancer stem cells

   • Ann H. Klopp
   • Wendy A. Woodward

   OriginalPaper 29 November 2009 Pages: 222 - 228

7. The importance of the epithelial-mesenchymal transition in breast cancer

   • Nathalie Sphyris
   • Sendurai A. Mani

   OriginalPaper 29 November 2009 Pages: 229 - 237

8. Systems biology of breast cancer

   • Adel Tabchy
   • Bryan T. Hennessy
   • Gordon B. Mills

   OriginalPaper 29 November 2009 Pages: 238 - 245